Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability

BACKGROUND: Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The myxovirus resistance protein A (MxA) gene expression is one of the most appropriate markers of biological activity of exogenous IFN-β. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonatė, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456985/
https://www.ncbi.nlm.nih.gov/pubmed/26009248
http://dx.doi.org/10.12659/MSM.894119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456985/
https://www.ncbi.nlm.nih.gov/pubmed/26009248
http://dx.doi.org/10.12659/MSM.894119

Ejemplares similares